These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6823029)

  • 1. Complications of intravenous phenytoin for acute treatment of seizures. Recommendations for usage.
    Earnest MP; Marx JA; Drury LR
    JAMA; 1983 Feb; 249(6):762-5. PubMed ID: 6823029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emergency phenytoin loading by constant intravenous infusion.
    Carducci B; Hedges JR; Beal JC; Levy RC; Martin M
    Ann Emerg Med; 1984 Nov; 13(11):1027-31. PubMed ID: 6385786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of acute seizures and status epilepticus with intravenous phenytoin.
    Leppik IE; Patrick BK; Cranford RE
    Adv Neurol; 1983; 34():447-51. PubMed ID: 6829350
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical use of intravenous phenytoin sodium infusions.
    Gannaway WL; Wilding DC; Siepler JK; King JH; Lee-Ow A
    Clin Pharm; 1983; 2(2):135-8. PubMed ID: 6883941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of intravenous phenytoin toxicity with demographic, clinical, and dosing parameters.
    Binder L; Trujillo J; Parker D; Cuetter A
    Am J Emerg Med; 1996 Jul; 14(4):398-401. PubMed ID: 8768165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenytoin administration by constant intravenous infusion: selective rates of administration.
    Donovan PJ; Cline D
    Ann Emerg Med; 1991 Feb; 20(2):139-42. PubMed ID: 1996794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe soft-tissue injury following intravenous infusion of phenytoin. Patient and drug administration risk factors.
    Spengler RF; Arrowsmith JB; Kilarski DJ; Buchanan C; Von Behren L; Graham DR
    Arch Intern Med; 1988 Jun; 148(6):1329-33. PubMed ID: 3377616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of individualized phenytoin sodium loading doses administered by intravenous infusion.
    Dela Cruz FG; Kanter MZ; Fischer JH; Leikin JB
    Clin Pharm; 1988 Mar; 7(3):219-24. PubMed ID: 3356118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and clinical consequence of the purple glove syndrome in patients receiving intravenous phenytoin.
    O'Brien TJ; Cascino GD; So EL; Hanna DR
    Neurology; 1998 Oct; 51(4):1034-9. PubMed ID: 9781525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine-phenytoin interaction. A cause of hypotension in the critically ill.
    Bivins BA; Rapp RP; Griffen WO; Blouin R; Bustrack J
    Arch Surg; 1978 Mar; 113(3):245-9. PubMed ID: 637689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenytoin intoxication.
    Murphy JM; Motiwala R; Devinsky O
    South Med J; 1991 Oct; 84(10):1199-204. PubMed ID: 1925719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized evaluation of adverse events and length-of-stay with routine emergency department use of phenytoin or fosphenytoin.
    Coplin WM; Rhoney DH; Rebuck JA; Clements EA; Cochran MS; O'Neil BJ
    Neurol Res; 2002 Dec; 24(8):842-8. PubMed ID: 12500711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Life-threatening cardiotoxicity due to chronic oral phenytoin overdose.
    Su CM; Kung CT; Wang YC; Lu CH
    Neurol India; 2009; 57(2):200-2. PubMed ID: 19439856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenytoin toxicity and blood levels after a large oral dose.
    Evens RP; Fraser DG; Ludden TM; Sutherland EW
    Am J Hosp Pharm; 1980 Feb; 37(2):232-5. PubMed ID: 7361796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review article: phenytoin use and efficacy in the ED.
    Gallop K
    Emerg Med Australas; 2010 Apr; 22(2):108-18. PubMed ID: 20534046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a method for intravenous phenytoin infusion.
    Boike SC; Rybak MJ; Tintinalli JE; Solomon DK; Powell MF; Trombley JH; Sacks C; Freeman S
    Clin Pharm; 1983; 2(5):444-6. PubMed ID: 6627872
    [No Abstract]   [Full Text] [Related]  

  • 17. Phenytoin (Dilantin) intoxication.
    Frantzen E; Hansen JM; Hansen OE; Kristensen M
    Acta Neurol Scand; 1967; 43(4):440-6. PubMed ID: 6081207
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative efficacy and safety of intravenous valproate and phenytoin in children.
    Rai A; Aggarwal A; Mittal H; Sharma S
    Pediatr Neurol; 2011 Nov; 45(5):300-4. PubMed ID: 22000309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hazards of doubling phenytoin dose in the face of an unrecognized interaction with ciprofloxacin.
    Pollak PT; Slayter KL
    Ann Pharmacother; 1997 Jan; 31(1):61-4. PubMed ID: 8997469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropsychiatric toxicity of phenytoin. Importance of monitoring phenytoin levels.
    Phelps SJ; Baldree LA; Boucher BA; Hogue SL
    Clin Pediatr (Phila); 1993 Feb; 32(2):107-10. PubMed ID: 8432072
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.